Overexpression of cell cycle inhibitors (p16(INK4) and p21(Cip1)) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells

Journal of the American Society of Nephrology

Volumn 8, Issue 1, 1997, Pages 51-60

  Terada, Yoshio ^a   Yamada, Takehisa ^a   Nakashima, Osamu ^a   Tamamori, Mimi ^a   Ito, Hiroshi ^a   Sasaki, Sei ^a   Marumo, Fumiaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL PROLIFERATION; GENE TRANSFER; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0030667946     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v8151     Document Type: Article

References (38)

1. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 43: 252-267, 1993
2. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 43: S48-S54, 1993
3. Abboud HE: Growth factors and the mesangium. J Am Soc Nephrol 2: S185-S189, 1992
4. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4: 119-128, 1993
5. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416, 1992
6. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597-2601, 1993
7. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603-608
8. Hunter T, Pines J: Cyclins and cancer: II - Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994
9. Sherr CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
10. Hunter T: Braking the cycle. Cell 75: 839-841, 1993
11. Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michaelides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6: 439-444, 1991
12. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bc11-linked candidate oncogene. Nature (Lond) 350: 512-515, 1991
13. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995
14. Noda A, Ning Y, Venable SF, Pereira SO, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98, 1994
15. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
16. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature (Lond) 366: 701-704, 1993
17. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ: Novel INK4 proteins p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15: 2672-2681
18. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond) 366: 704-707, 1993
19. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993
20. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr CJ: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487-496, 1994
21. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ: Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75: 207-216, 1993
22. Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, Ferry N: Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 45: 1220-1225, 1994
23. Chang H, Katoh T, Noda M, Kanegae Y, Saito I, Asano S, Kurokawa K: Highly efficient adenovirus-mediated gene transfer into renal cells in culture. Kidney Int 47: 322-326, 1995
24. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl Acids Res 23: 3816-3821, 1995
25. Miyake S, Makimura Y, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I: Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full length virus genome. Proc Natl Acad Sci U S A 93: 1320-1324, 1996
26. Koh J, Enders GH, Dynlacht BD, Harlow E: Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond) 375: 506-510, 1995
27. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713, 1991
28. Owada A, Tomita K, Terada Y, Sakamoto H, Nonoguchi H, Marumo F: Endothelin (ET)-3 stimulates cyclic guanosine 3′,5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J Clin Invest 93: 556-563, 1994
29. Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912, 1993
30. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076, 1994
31. Li R, Waga S, Hannon GJ, Beach D, Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond) 371: 534-537, 1994
32. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994
33. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by p18, a p16INK4/ MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939-2952, 1994
34. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond) 375: 503-506, 1995
35. Serrano M, Gomez LE, DePinho RA, Beach D, Bar SD: Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267: 249-252, 1995
36. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983, 1992
37. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8: 3447-3457, 1993
38. Quelle DE, Ashmun RA, Shurtleff SA, Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571, 1993